日本語English简体中文 繁體中文

4892 Cyfuse Biomedical K.K.サイフューズTSE Growth / Pharmaceuticals

0 posts

Cyfuse Biomedical K.K. (4892) at a glance

Code
4892
Company
Cyfuse Biomedical K.K.
Local name
サイフューズ
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥487 -16.0 (-3.18%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Cyfuse Biomedical K.K. (4892) Stock Price HistoryNear a 52-week low

Cyfuse Biomedical K.K. closed at ¥487 on Nov 20, 2026, −17.2% over 1 month, −16.6% over 1 year.

2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥595¥487Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥595Oct 21
1-Month Low¥487Nov 20
1-Week Change−5.3%vs Nov 13
1-Month Change−17.2%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥82,823 today (−17.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −17.2%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥487−16−3.18%
Nov 19 (Thu)¥503−12−2.33%
Nov 18 (Wed)¥515+12+2.39%
Nov 17 (Tue)¥503−3−0.59%
Nov 16 (Mon)¥506−8−1.56%
Nov 13 (Fri)¥514−11−2.10%
Nov 12 (Thu)¥525−20−3.67%
Nov 11 (Wed)¥545+10+1.87%
Nov 10 (Tue)¥535+21+4.09%
Nov 9 (Mon)¥514+14+2.80%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥696¥487Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥696Sep 18
3-Month Low¥487Nov 20
1-Month Change−17.2%vs Oct 20
3-Month Change−14.6%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥85,439 today (−14.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −14.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥487−16−3.18%
Nov 19 (Thu)¥503−12−2.33%
Nov 18 (Wed)¥515+12+2.39%
Nov 17 (Tue)¥503−3−0.59%
Nov 16 (Mon)¥506−8−1.56%
Nov 13 (Fri)¥514−11−2.10%
Nov 12 (Thu)¥525−20−3.67%
Nov 11 (Wed)¥545+10+1.87%
Nov 10 (Tue)¥535+21+4.09%
Nov 9 (Mon)¥514+14+2.80%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥696¥487May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥696Sep 18
6-Month Low¥487Nov 20
3-Month Change−14.6%vs Aug 20
6-Month Change−18.4%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥81,575 today (−18.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −18.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥487−12.9%
Oct 2026¥559−16.3%
Sep 2026¥668+19.3%
Aug 2026¥560+8.1%
Jul 2026¥518−5.8%
Jun 2026¥550−6.8%
May 2026¥590−13.1%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥757¥487Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥757Apr 22
52-Week Low¥487Nov 20
Year to Date−17.5%vs Dec 30
From 52-Week High−35.7%Apr 22

If you had invested ¥100,000 1 year ago, it would be worth ¥83,390 today (−16.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −16.6%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥487−12.9%
Oct 2026¥559−16.3%
Sep 2026¥668+19.3%
Aug 2026¥560+8.1%
Jul 2026¥518−5.8%
Jun 2026¥550−6.8%
May 2026¥590−13.1%
Apr 2026¥679+14.9%
Mar 2026¥591−11.5%
Feb 2026¥668+4.0%
Jan 2026¥642+8.8%
Dec 2025¥590−3.3%
Nov 2025¥610―
¥1,320¥441Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥1,320Feb 24, 2025
3-Year Low¥441Jan 13, 2025
Annualized Return−15.6%
Max Drawdown−63.1%

If you had invested ¥100,000 3 years ago, it would be worth ¥60,198 today (−39.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −39.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥487−17.5%
2025¥590―
¥2,214¥441Nov 28, 2022Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥2,214Nov 28, 2022
5-Year Low¥441Jan 13, 2025
Annualized Return−31.7%
Max Drawdown−80.1%

If you had invested ¥100,000 5 years ago, it would be worth ¥21,996 today (−78.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +103.2%, while this stock moved −78.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥487−17.5%
2025¥590―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Nov 2022). Please check the latest prices before trading.

Cyfuse Biomedical K.K. (4892) financial indicators

PBR
2.15
ROE
-48.77%
Dividend yield
0.00%

See all financial indicators for Cyfuse Biomedical K.K. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Cyfuse Biomedical K.K. (4892)

Business overview

Since its founding in 2010, under its corporate philosophy of contributing to dramatic advances in medicine through the practical use of innovative 3D cell stacking technology, the company has been a regenerative medicine venture aiming to deliver three-dimensional tissues and organs made only from cells as 3D cell products to advanced medical settings such as regenerative medicine and drug discovery. It has a single segment covering R&D, manufacturing and sales of cell products and more. In regenerative medicine, it develops a pipeline toward practical regenerative medicine products and takes on contract work for research-use 3D cell products. In drug discovery support, it develops and sells 3D cell products that support the drug discovery activities of pharmaceutical companies and non-clinical testing contractors. In devices, it develops and sells 3D cell stacking systems such as bio 3D printers equipped with its core technology. While artificial materials such as gels and collagen have conventionally been used, it has its own technology for making three-dimensional tissues and organs from cells alone without artificial materials.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR2.15xAbove the sector median of 1.86x (No. 46 from the lowest)
ROE-48.77%No. 45 in the sector (highest first); median 4.17%
Market cap¥4.9 bnNo. 65 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥7574/22
52-week low¥48711/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: ¥487)
Year to date-17.5%No. 42 of 77 in the sector (best first)
1 year-16.6%

Based on closing prices (adjusted for stock splits, excluding dividends).

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (3).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Cyfuse Biomedical K.K. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English